Why the study?
Does comprehensive familial screening including genetic testing identify arrhythmogenic variant carriers in patients with acute myocarditis and a family history of cardiomyopathy or sudden death?
Does comprehensive familial screening including genetic testing identify arrhythmogenic variant carriers in patients with acute myocarditis and a family history of cardiomyopathy or sudden death?
Acute myocarditis should be considered an additional criterion for arrhythmogenic cardiomyopathy, and genetic testing is advised in patients with acute myocarditis and a family history of cardiomyopathy or sudden death.
Answers are grounded in this paper and cite their sources.
Supports considering genetic testing in acute myocarditis with family history; leaves open expansion of arrhythmogenic cardiomyopathy criteria.
Comprehensive familial screening including genetic testing in case of acute myocarditis associated with a family history of cardiomyopathy or sudden death revealed unknown or misdiagnosed arrhythmogenic variant carriers with left-dominant phenotypes that frequently evade arrhythmogenic right ventricular cardiomyopathy Task Force criteria. In view of our results, acute myocarditis should be considered as an additional criterion for arrhythmogenic cardiomyopathy, and genetic testing should be advised in patients who experience acute myocarditis and have a family history of cardiomyopathy or sudden death.
No takes yet. Share an insight, caveat, or question.
Piriou et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: